A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus
Authors:
- 1 July 2014
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 71 (1) , 84-91
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010British Journal of Dermatology, 2010
- Safety and Tolerability of Adjuvant Topical Tacrolimus Treatment in Boys with Lichen Sclerosus: A Prospective Phase 2 StudyEuropean Urology, 2008
- Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal womenInternational Journal of Dermatology, 2007
- Successful treatment of vulvar lichen sclerosus in a child with low‐concentration topical tacrolimus ointmentThe Journal of Dermatology, 2007
- Vulvar Lichen Sclerosus: 11 Women Treated with Tacrolimus 0.1% OintmentActa Dermato-Venereologica, 2007
- Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosusBritish Journal of Dermatology, 2006
- Topical tacrolimus in the management of lichen sclerosusBJOG: An International Journal of Obstetrics & Gynaecology, 2006
- Vulvar lichen sclerosus successfully treated with topical tacrolimusEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2005
- Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girlJournal of Pediatric and Adolescent Gynecology, 2004
- Human Papillomavirus–Negative Spindle Cell Carcinoma of the Vulva Associated With Lichen SclerosusThe American Journal of Dermatopathology, 2002